IT9021370A0 - Composizioni farmaceutiche con migliorate proprieta' di dissoluzione. - Google Patents

Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.

Info

Publication number
IT9021370A0
IT9021370A0 IT9021370A IT2137090A IT9021370A0 IT 9021370 A0 IT9021370 A0 IT 9021370A0 IT 9021370 A IT9021370 A IT 9021370A IT 2137090 A IT2137090 A IT 2137090A IT 9021370 A0 IT9021370 A0 IT 9021370A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
dissolution properties
improved dissolution
improved
properties
Prior art date
Application number
IT9021370A
Other languages
English (en)
Other versions
IT9021370A1 (it
IT1246445B (it
Inventor
Alessandro Martini
Clara Torricelli
Carlo Confalonieri
Ponti Roberto De
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of IT9021370A0 publication Critical patent/IT9021370A0/it
Publication of IT9021370A1 publication Critical patent/IT9021370A1/it
Application granted granted Critical
Publication of IT1246445B publication Critical patent/IT1246445B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT02137090A 1989-09-06 1990-09-04 Composizioni farmaceutiche con migliorate proprieta' di dissoluzione. IT1246445B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898920135A GB8920135D0 (en) 1989-09-06 1989-09-06 Use of dehydrated cyclodextrins for improving drug dissolution

Publications (3)

Publication Number Publication Date
IT9021370A0 true IT9021370A0 (it) 1990-09-04
IT9021370A1 IT9021370A1 (it) 1992-03-04
IT1246445B IT1246445B (it) 1994-11-18

Family

ID=10662618

Family Applications (1)

Application Number Title Priority Date Filing Date
IT02137090A IT1246445B (it) 1989-09-06 1990-09-04 Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.

Country Status (5)

Country Link
US (1) US5126333A (it)
JP (1) JP2948886B2 (it)
DE (1) DE4028004A1 (it)
GB (2) GB8920135D0 (it)
IT (1) IT1246445B (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
GB9419153D0 (en) * 1994-09-22 1994-11-09 Erba Carlo Spa Estramustine formulations with improved pharmaceutical properties
CA2167362A1 (en) * 1995-02-10 1996-08-11 Alexei Dmitri Klimov Apparatus and method for conducting a binding assay on an absorbent carrier material
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
MXPA04001453A (es) * 2001-08-15 2004-05-20 Cellresint Technologies Llc Materiales de embalaje con propiedades de aislamiento mejoradas.
BRPI0105509B8 (pt) * 2001-11-05 2021-05-25 Univ Minas Gerais formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
RU2006141358A (ru) * 2004-04-23 2008-05-27 Сайдекс, Инк. (Us) Препаративная форма для ингалятора сухого порошка, содержащая простой сульфоалкиловый эфир циклодекстрина
GB0813628D0 (en) * 2008-07-25 2008-09-03 Arrow Int Ltd Stable coated anti-cancer agent
JP5830412B2 (ja) * 2011-03-02 2015-12-09 ライオン株式会社 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5661369A (en) * 1979-10-26 1981-05-26 Iwaki Seiyaku Kk Inclusion compound of thialamide or its acid addition salt
EP0138485B1 (en) * 1983-09-29 1990-04-04 Nippon Telegraph And Telephone Corporation Radio reception system for a phase modulation signal
JPS6121184A (ja) * 1984-07-10 1986-01-29 Mitsubishi Electric Corp 水溶性酸化防止剤の製造方法
SU1357410A1 (ru) * 1985-01-24 1987-12-07 Предприятие П/Я Р-6710 Способ получени соединений включени @ -циклодекстрина и инертных газов
JPS62267261A (ja) * 1986-05-14 1987-11-19 Ichimaru Pharcos Co Ltd β−カロチン包接物
JPH0764884B2 (ja) * 1986-11-27 1995-07-12 株式会社トクヤマ シクロデキストリン組成物

Also Published As

Publication number Publication date
GB2236252A (en) 1991-04-03
IT9021370A1 (it) 1992-03-04
US5126333A (en) 1992-06-30
IT1246445B (it) 1994-11-18
GB8920135D0 (en) 1989-10-18
GB9019236D0 (en) 1990-10-17
JP2948886B2 (ja) 1999-09-13
GB2236252B (en) 1993-03-17
JPH0393732A (ja) 1991-04-18
DE4028004A1 (de) 1991-03-07

Similar Documents

Publication Publication Date Title
FI901102A0 (fi) Farmaceutiska kompositioner.
FI922364A (fi) Farmaceutiska kompositioner.
IT8920486A0 (it) Composizioni farmaceutiche.
DE69115263D1 (de) Pharmazeutische zusammensetzungen.
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
FI943569A0 (fi) Hyviä liukenemisominaisuuksia omaavia farmaseuttisia koostumuksia
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
FR2654223B1 (fr) Protection d'objectif.
IT8820386A0 (it) Composizioni farmaceutiche orosolubili contenti acetilcisteina.
DK0426806T3 (da) Polymersammensætninger
FI893643A (fi) Farmaceutiska kompositioner.
IT1246445B (it) Composizioni farmaceutiche con migliorate proprieta' di dissoluzione.
DE69007908D1 (de) Shampoo-Zusammensetzung.
IT9019754A0 (it) Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
DE69012664D1 (de) Kältezusammensetzungen.
UA26064A1 (uk) Фармацевтичhа композиція
DE69013711D1 (de) Polymerzusammensetzung.
NO933506D0 (no) Ioderte fuktemidler
IT1206513B (it) Composizioni farmaceutiche adattivita'antibiotica-immunostimolante.
IT219116Z2 (it) "siringa di sicurezza"
FR2654123B1 (fr) Solution d'agent de blanchiment fluorescent.
MA21961A1 (fr) Compositions fumigastriques eppaissies .
DE69003003D1 (de) Pharmazeutische Zusammensetzung.
IT1215261B (it) Composizioni farmaceutiche adattivita' antigalattopoietica.
FR2655252B1 (fr) Porte-etagere d'angle.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970929